Circulating endothelial progenitor cells are increased in human lung cancer and correlate with stage of disease

European Journal of Cardio-thoracic Surgery

Volumn 37, Issue 4, 2010, Pages 758-763

  Nowak, Kai ^a   Rafat, Neysan ^b,c   Belle, Sebastian ^a   Weiss, Christel ^d   Hanusch, Christine ^b   Hohenberger, Peter ^a   Beck, Grietje Ch ^b  

^a University Medical Center Mannheim   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Angiogenesis; Endothelial progenitor cells; Endothelium; Lung cancer

Indexed keywords

CARBOPLATIN; CD133 ANTIGEN; CD34 ANTIGEN; CISPLATIN; ETOPOSIDE; FICOLL; GEMCITABINE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CELL COUNT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; LOG RANK TEST; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; STEM CELL;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CASE-CONTROL STUDIES; CELL COUNT; DISEASE PROGRESSION; ENDOTHELIAL CELLS; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77949485206     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.10.002     Document Type: Article

References (24)

1. Spiro S.G., and Silvestri G.A. One hundred years of lung cancer. Am J Respir Crit Care Med 172 (2005) 523-529
2. Herbst R.S., Onn A., and Sandler A. Angiogenesis and lung cancer: prognostic and therapeutic implications. J Clin Oncol 23 (2005) 3243-3256
3. Asahara T., and Kawamoto A. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol 287 (2004) C572-C579
4. Davidoff A.M., Ng C.Y., Brown P., Leary M.A., Spurbeck W.W., Zhou J., Horwitz E., Vanin E.F., and Nienhuis A.W. Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice. Clin Cancer Res 7 (2001) 2870-2879
5. Hilbe W., Dirnhofer S., Oberwasserlechner F., Schmid T., Gunsilius E., Hilbe G., Wöll E., and Kähler C.M. CD 133 positive endothelial progenitor cells contribute to the tumor vasculature in non-small cell lung cancer. J Clin Pathol 57 (2005) 965-969
6. Dome B., Timar J., Dobos J., Meszaros L., Raso E., Paku S., Kenessey I., Ostoros G., Magyar M., Ladanyi A., Bogos K., and Tovari J. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res 66 (2006) 7341-7347
7. Yoon C.H., Hur J., Park K.W., Kim J.H., Lee C.S., Oh I.Y., Kim T.Y., Cho H.J., Kang H.J., Chae I.H., Yang H.K., Oh B.H., Park Y.B., and Kim H.S. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 112 (2005) 1618-1627
8. Reck M., von Pawel J., Zatloukal P., Ramlau R., Gorbounova V., Hirsh V., Leighl N., Mezger J., Archer V., Moore N., and Manegold C. Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil. J Clin Oncol 27 (2009) 1227-1234
9. Sharma S., Sharma M.C., and Sarkar C. Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology 46 (2005) 481-489
10. Bhatt R.S., Seth P., and Sukhatme V.P. Biomarkers for monitoring antiangiogenetic therapy. Clin Cancer Res 13 (2007) 777S-780S
11. Rafat N., Hanusch C., Brinkkoetter P.T., Schulte J., Brade J., Zijlstra J.G., van der Woude F.J., van Ackern K., Yard B.A., and Beck G.Ch. Increased circulating endothelial progenitor cells in septic patients: correlation with survival. Crit Care Med 35 (2007) 1677-1684
12. Dome B., Hendrix M.C., Paku S., Tovari J., and Timar J. Alternative vascularization mechanisms in cancer. Am J Pathol 170 (2007) 1-15
13. Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Butros L., Chadburn A., Heissig B., Marks W., Witte L., Wu Y., Hicklin D., Zhu Z., Hackett N.R., Crystal R.G., Moore M.A., Hajjar K.A., Manova K., Benezra R., and Rafii S. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7 (2001) 1194-1201
14. Khan S.S., Solomon M.A., and McCoy Jr. J.P. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom 64 (2005) 1-8
15. Peichev M., Naiver A.J., Pereira D., Zhu Z., Lane W.J., Williams M., Oz M.C., Hicklin D.J., Witte L., Moore M.A., and Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
16. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., and Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348 (2003) 593-600
17. Shantsila E., Watson T., Tse H.F., and Lip G.Y. Endothelial colony forming units: are they a reliable marker of endothelial progenitor cell numbers?. Ann Med 39 (2007) 474-479
18. Urbich C., and Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95 (2004) 343-353
19. Fadini G.P., Schiavon M., Cantini M., Baesso I., Facco M., Miorin M., Tassinato M., de Kreutzenberg S.V., Avogaro A., and Agostini C. Circulating progenitor cells are reduced in patients with severe lung disease. Stem Cells 24 (2006) 1806-1813
20. Spring H., Schüler T., Arnold B., Hämmerling G.J., and Ganss R. Chemokine direct endothelial progenitors into tumor neovessels. Proc Natl Acad Sci U S A 102 (2005) 18111-18116
21. Imoto H., Osaki T., Taga S., Ohgami A., Ichiyoshi Y., and Yasumoto K. Vascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma. J Thorac Cardiovasc Surg 115 (1998) 1007-1014
22. Pircher A., Kahler C.M., Skvortsov S., Dlaska M., Kawaguchi G., Schmid T., Gunsilius E., and Hilbe W. Increased numbers of endothelial progenitor cells in peripheral blood and tumor specimens in non-small cell lung cancer: a methodological challenge and an ongoing debate on the clinical relevance. Oncol Rep 19 (2008) 345-352
23. Yamazaki K., Abe S., Takekawa H., Sukoh N., Watanabe N., Ogura S., Nakajima I., Isobe H., Inoue K., and Kawakami Y. Tumor angiogenesis in human lung adenocarcinoma. Cancer 74 (1994) 2245-2250
24. Imai K., and Takaoka A. Comparing antibody and small-molecule therapies for cancer. Nat Rev Cancer 6 (2006) 714-727